Biologika - Company finances
|
EUR
|
2023
From: 2023-08-22
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 15,410 | 175,764 | 105,788 |
| Profit before tax | 821 | 2,243 | 10,016 |
| Net profit | 698 | 1,907 | 8,414 |
| Equity | 1,698 | 3,605 | 12,019 |
| Liabilities | 2,628 | 12,650 | 26,928 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 4,326 | 16,255 | 38,947 |
| Total assets | 4,326 | 16,255 | 38,947 |
|
Taxes paid
|
|||
| STI taxes | 973 | 27,707 | 11,219 |
| Social insurance contributions | - | - | 5,962 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +1040.6% | -39.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 16.1% | 11.7% | 21.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 41.1% | 52.9% | 70.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.5% | 1.1% | 8.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.3% | 1.3% | 9.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.5 | 3.5 | 2.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 8,806 | 65,911 | 28,851 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biologika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-26 | 2026-08-26 | 659.41 |
| 2026-08-23 | 2026-08-23 | 659.41 |
| 2026-08-19 | 2026-08-19 | 659.41 |
| 2026-08-16 | 2026-08-17 | 9.31 |
| 2026-08-04 | 2026-08-14 | 9.31 |
| 2026-07-30 | 2026-08-03 | 78.49 |
| 2026-07-27 | 2026-07-29 | 147.54 |
| 2026-07-26 | 2026-07-26 | 138.23 |
| 2026-07-24 | 2026-07-25 | 78.36 |
| 2026-07-23 | 2026-07-23 | 599.20 |
| 2026-07-21 | 2026-07-22 | 589.89 |
| 2026-07-19 | 2026-07-20 | 659.07 |
| 2026-07-16 | 2026-07-17 | 659.07 |
| 2026-06-25 | 2026-06-25 | 577.04 |
| 2026-06-16 | 2026-06-24 | 654.49 |
| 2026-05-27 | 2026-06-01 | 629.55 |
| 2026-05-17 | 2026-05-26 | 636.90 |
| 2026-05-12 | 2026-05-14 | 6.36 |
| 2026-05-03 | 2026-05-11 | 605.84 |
| 2026-04-29 | 2026-04-29 | 605.84 |
| 2026-04-27 | 2026-04-28 | 621.23 |
| 2026-04-26 | 2026-04-26 | 614.87 |
| 2026-04-24 | 2026-04-25 | 621.23 |
| 2026-04-20 | 2026-04-23 | 614.87 |
| 2026-03-27 | 2026-03-27 | 587.17 |
| 2026-03-17 | 2026-03-24 | 587.17 |
| 2026-02-18 | 2026-02-26 | 486.41 |
| 2026-01-21 | 2026-02-05 | 664.76 |
| 2026-01-16 | 2026-01-20 | 657.49 |
| 2026-01-01 | 2026-01-12 | 182.96 |
| 2025-12-29 | 2025-12-30 | 182.96 |
| 2025-12-16 | 2025-12-28 | 661.29 |
| 2025-11-18 | 2025-11-27 | 672.22 |
| 2025-10-28 | 2025-11-17 | 6.30 |
| 2025-10-23 | 2025-10-27 | 670.68 |
| 2025-10-16 | 2025-10-22 | 664.38 |
| 2025-09-16 | 2025-09-24 | 661.29 |
| 2025-08-28 | 2025-08-29 | 672.09 |
| 2025-08-19 | 2025-08-26 | 672.09 |
| 2025-08-01 | 2025-08-18 | 6.17 |
| 2025-07-24 | 2025-07-31 | 661.58 |
| 2025-07-16 | 2025-07-23 | 661.29 |
| 2025-06-17 | 2025-06-26 | 662.83 |
| 2025-05-16 | 2025-05-28 | 668.88 |
| 2025-05-04 | 2025-05-15 | 7.59 |
| 2025-04-30 | 2025-04-30 | 630.47 |
| 2025-04-25 | 2025-04-29 | 7.59 |
| 2025-04-24 | 2025-04-24 | 638.06 |
| 2025-04-16 | 2025-04-23 | 630.47 |
| 2025-03-27 | 2025-04-03 | 592.63 |
| 2025-03-18 | 2025-03-26 | 630.47 |
| 2025-03-03 | 2025-03-03 | 630.47 |
| 2025-02-18 | 2025-02-26 | 630.47 |
| 2025-02-10 | 2025-02-10 | 837.90 |
| 2025-01-22 | 2025-01-27 | 837.90 |
| 2025-01-16 | 2025-01-21 | 828.16 |
| 2025-01-06 | 2025-01-15 | 253.03 |
| 2025-01-02 | 2025-01-05 | 575.13 |
| 2024-12-22 | 2024-12-31 | 575.13 |
| 2024-12-17 | 2024-12-20 | 575.13 |
| 2024-12-06 | 2024-12-10 | 300.32 |
| 2024-11-18 | 2024-12-05 | 580.12 |
| 2024-10-29 | 2024-11-17 | 4.99 |
| 2024-10-28 | 2024-10-28 | 139.21 |
| 2024-10-24 | 2024-10-27 | 580.12 |
| 2024-10-16 | 2024-10-23 | 575.13 |
| 2024-09-17 | 2024-09-22 | 575.13 |
| 2024-09-03 | 2024-09-04 | 569.78 |
| 2024-08-19 | 2024-09-02 | 572.31 |
| 2024-07-16 | 2024-07-17 | 572.69 |
| 2024-06-18 | 2024-06-19 | 562.56 |
Biologika - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Biologika is: 499 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 498.75 |
| 2026-08-28 | 2026-08-31 | 498.19 |
| 2026-08-25 | 2026-08-27 | 217.85 |
| 2026-08-14 | 2026-08-24 | 216.65 |
| 2026-08-02 | 2026-08-13 | 105.68 |
| 2026-04-13 | 2026-04-15 | 334.77 |
| 2026-02-16 | 2026-02-21 | 115.62 |
| 2026-02-03 | 2026-02-15 | 1607.94 |
| 2026-01-31 | 2026-02-02 | 1605.14 |
| 2026-01-29 | 2026-01-30 | 1600.06 |
| 2026-01-23 | 2026-01-28 | 196.06 |
| 2026-01-22 | 2026-01-22 | 196.48 |
| 2026-01-16 | 2026-01-21 | 114.28 |
| 2026-01-14 | 2026-01-15 | 0.4 |
| 2026-01-01 | 2026-01-13 | 906.4 |
| 2025-12-30 | 2025-12-31 | 126.15 |
| 2025-12-24 | 2025-12-29 | 444.04 |
| 2025-12-23 | 2025-12-23 | 489.63 |
| 2025-12-17 | 2025-12-22 | 485.08 |
| 2025-12-05 | 2025-12-16 | 2.38 |
| 2025-12-03 | 2025-12-04 | 1301.48 |
| 2025-12-01 | 2025-12-02 | 1300.8 |
| 2025-11-28 | 2025-11-30 | 1299.0 |
| 2025-11-27 | 2025-11-27 | 2.0 |
| 2025-11-25 | 2025-11-26 | 185.91 |
| 2025-11-12 | 2025-11-24 | 183.91 |
| 2025-11-02 | 2025-11-07 | 2413.84 |
| 2025-10-30 | 2025-11-01 | 2465.96 |
| 2025-10-17 | 2025-10-29 | 54.66 |
| 2025-09-23 | 2025-09-23 | 171.63 |
| 2025-09-16 | 2025-09-22 | 191.32 |
| 2025-09-05 | 2025-09-15 | 7.24 |
| 2025-09-02 | 2025-09-04 | 494.17 |
| 2025-09-01 | 2025-09-01 | 495.24 |
| 2025-08-31 | 2025-08-31 | 490.63 |
| 2025-08-28 | 2025-08-30 | 488.0 |
| 2025-08-24 | 2025-08-27 | 245.94 |
| 2025-08-14 | 2025-08-23 | 633.8 |
| 2025-08-02 | 2025-08-13 | 0.06 |
| 2025-07-31 | 2025-08-01 | 54.46 |
| 2025-07-28 | 2025-07-30 | 54.66 |
| 2025-06-19 | 2025-06-20 | 629.25 |
| 2025-06-10 | 2025-06-18 | 293.25 |
| 2025-06-04 | 2025-06-09 | 4.1 |
| 2025-06-02 | 2025-06-03 | 2784.03 |
| 2025-05-29 | 2025-06-01 | 2779.93 |
| 2025-05-28 | 2025-05-28 | 351.93 |
| 2025-05-24 | 2025-05-27 | 349.63 |
| 2025-05-17 | 2025-05-23 | 349.18 |
| 2025-05-01 | 2025-05-16 | 244.83 |
| 2025-04-30 | 2025-04-30 | 243.56 |
| 2025-04-28 | 2025-04-29 | 243.0 |
| 2025-04-16 | 2025-04-23 | 141.33 |
| 2025-04-05 | 2025-04-15 | 1.32 |
| 2025-04-02 | 2025-04-04 | 819.37 |
| 2025-03-28 | 2025-04-01 | 818.05 |
| 2025-03-25 | 2025-03-27 | 10.05 |
| 2025-03-15 | 2025-03-24 | 9.8 |
| 2025-02-12 | 2025-02-24 | 159.17 |
| 2025-01-31 | 2025-01-31 | 494.13 |
| 2025-01-30 | 2025-01-30 | 510.04 |
| 2025-01-29 | 2025-01-29 | 105.16 |
| 2025-01-28 | 2025-01-28 | 569.16 |
| 2025-01-17 | 2025-01-27 | 571.53 |
| 2025-01-06 | 2025-01-16 | 465.88 |
| 2025-01-01 | 2025-01-05 | 525.18 |
| 2024-12-30 | 2024-12-31 | 523.99 |
| 2024-12-22 | 2024-12-29 | 59.99 |
| 2024-12-12 | 2024-12-21 | 108.78 |
| 2024-12-11 | 2024-12-11 | 652.39 |
| 2024-12-08 | 2024-12-10 | 651.49 |
| 2024-12-07 | 2024-12-07 | 1155.85 |
| 2024-12-03 | 2024-12-06 | 1051.5 |
| 2024-11-28 | 2024-12-02 | 1049.71 |
| 2024-11-23 | 2024-11-27 | 4.71 |
| 2024-11-08 | 2024-11-22 | 478.79 |
| 2024-10-10 | 2024-10-16 | 1063.19 |
| 2024-10-09 | 2024-10-09 | 5362.01 |
| 2024-10-06 | 2024-10-08 | 5353.29 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biologika, UAB (code 306386177) is a Private Limited Liability Company operating in non-specialised retail sale of predominately food, beverages or tobacco. In 2025, the company generated €105.8K in revenue and €8.4K in net profit, compared with €175.8K revenue and €1.9K net profit in 2024. Revenue fell 39.8% year on year, but profitability improved materially, lifting the net profit margin to 8.0% from 1.1% in the prior year. Over the two-year period, revenue increased strongly from €15.4K in 2023 to €105.8K in 2025, although the 2023 figures cover a 131-day period. The balance sheet strengthened in 2025, with total assets of €38.9K, equity of €12.0K and liabilities of €26.9K. Equity represented 30.9% of assets, while debt-to-equity stood at 2.24. Return on equity was 70.0% and return on assets 21.6%, supported by an asset turnover of 2.72x. Revenue per employee was €35.3K and profit per employee €2.8K, indicating modest but positive productivity.